Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2299-2303

  Vora, Shefali ^a   Chauhan, Sharda ^a   Brummer, Elmer ^a,b,c   Stevens, David A ^a,b,c  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; DYE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VORICONAZOLE;

ARTICLE; ASPERGILLUS FUMIGATUS; COCULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG POTENTIATION; FUNGICIDAL ACTIVITY; GROWTH INHIBITION; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

EID: 0031713711     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2299     Document Type: Article

References (12)

1. Brummer, E., and D. A. Stevens. 1996. Synergy of human neutrophils with fluconazole in killing Candida species. Mycopathologia 134:115-120.
2. Denning, D. W., A. del Favero, E. Gluckman, D. Norfolk, M. Ruhnke, S. Yonren, P. Troke, and N. Sarantis. 1996. UK-109,496, a novel wide-spectrum triazole derivative for treatment of fungal infections: clinical efficacy in acute invasive aspergillosis, abstr. F80, p. 126. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Denning, D. W., L. H. Hanson, A. M. Perlman, and D. A. Stevens. 1992. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn. Microbiol. Infect. Dis. 15:21-34.
4. Denning, D. W., and D. A. Stevens. 1990. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis. 12: 1147-1199.
5. Garcha, U. K., E. Brummer, and D. A. Stevens. 1995. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing Candida species. J. Infect. Dis. 172:1620-1623.
6. Gujral, S., E. Brummer, and D. A. Stevens. 1996. Role of extended culture time on synergy of fluconazole and human monocyte-derived macrophages in clearing Candida albicans. J. Infect. Dis. 174:888-889.
7. Hitchcock, C. A., G. E. Pye, G .P. Oliver, and P. F. Troke. 1996. UK-109,496, a novel wide-spectrum triazole derivative for the treatment of fungal infections: antifungal activity and selectivity in vitro, abstr. F72, p. 125. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. Levitz, S. M., and R. D. Diamond. 1985. A rapid colorimetric assay for fungal viability with the tetrazolium salt MTT. J. Infect. Dis. 152:938-945.
9. Meshulam, T., S. M. Levitz, L. Christian, and R. D. Diamond. 1995. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-tetrazolium-5-carboxanilide (XTT). J. Infect. Dis. 172:1153-1156.
10. Oakley, K. L., C. B. Moore, and D. W. Denning. 1996. In vitro activity of voriconazole against Aspergillus spp. and comparison with amphotericin B and itraconazole, abstr. F81, p. 114. In Abstracts of the 36th Interscience Conference on Antimicrobiol Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. Roilides, E., A. Holmes, C. Blake, D. Venzon, P. A. Pizzzo, and T. J. Walsh. 1994. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma. J. Infect. Dis. 170:894-899.
12. Roilides, E., K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1993. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun. 61:1185-1193.